SEC Form 4 · accession 0001209191-15-043953
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian F Smith
Officer — EVP & CFO
Period of report
May 15, 2015
Accepted (ET)
May 18, 2015 · 6:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2015 | S | 100 | $123.85 | D | 118,412 | D | |
| Common Stock | May 15, 2015 | S | 178 | $125.84 | D | 118,234 | D | |
| Common Stock | May 15, 2015 | S | 100 | $126.99 | D | 118,134 | D | |
| Common Stock | holding | — | — | — | 5,306 | I | 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.